The prices that pharmacies like Walgreens pay for generic drugs has been falling, but not as fast as insurers’ reimbursement rates, and the shrinking gap between the price Walgreens pays and the amount it receives after dispensing the drug is reducing the company’s profit margins. Other health industry news covers the legal struggles over a popular weedkiller that's been linked to cancer, an innovated approach to cutting costs, and caregiving benefits.
from Kaiser Health News https://ift.tt/2HXDWnZ
April 03, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Nursing Home Industry Wants Trump To Rescind Staffing MandateCovid’s rampage through the country’s nursing homes killed more than 172,000 residents and spurred the biggest industry reform in decades: a mandate that homes employ a minimum number of nurses. But with President-elect Donal… Read More
9 States Poised To End Coverage for Millions if Trump Cuts Medicaid FundingWith Donald Trump’s return to the White House and Republicans taking full control of Congress in 2025, the Affordable Care Act’s Medicaid expansion is back on the chopping block. More than 3 million adults in nine states woul… Read More
Who Gets Obesity Drugs Covered by Insurance? In North Carolina, It Helps If You’re on MedicaidAfter losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don’t work. So when the University of North Carolina-Charlotte professor learned that Ozempic — develope… Read More
An Arm and a Leg: New Lessons in the Fight for Charity CareFederal law requires that all nonprofit hospitals have financial assistance policies — also known as “charity care” — to reduce or expunge people’s medical bills. New research from Dollar For, an organization dedicated to hel… Read More
Qué es el movimiento para “Hacer a América saludable de nuevo” (MAHA)Días después de la victoria electoral de Donald Trump, el empresario de salud Calley Means recurrió a las redes sociales en busca de consejos. “Primeros 100 días”, escribió Means, ex consultor de la industria farmacéutica que… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment